BSACI guideline for the diagnosis and management of peanut and tree nut allergy
Summary Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK....
Saved in:
| Published in | Clinical and experimental allergy Vol. 47; no. 6; pp. 719 - 739 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
01.06.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0954-7894 1365-2222 1365-2222 |
| DOI | 10.1111/cea.12957 |
Cover
| Abstract | Summary
Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE‐mediated symptoms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usually mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food challenges are usually not necessary but may be used to confirm or refute a conflicting history and test result. As nut allergy is likely to be a long‐lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehensive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medication. Regular re‐training is required. |
|---|---|
| AbstractList | Summary
Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE‐mediated symptoms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usually mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food challenges are usually not necessary but may be used to confirm or refute a conflicting history and test result. As nut allergy is likely to be a long‐lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehensive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medication. Regular re‐training is required. Summary Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE-mediated symptoms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usually mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food challenges are usually not necessary but may be used to confirm or refute a conflicting history and test result. As nut allergy is likely to be a long-lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehensive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medication. Regular re-training is required. Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE-mediated symptoms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usually mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food challenges are usually not necessary but may be used to confirm or refute a conflicting history and test result. As nut allergy is likely to be a long-lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehensive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medication. Regular re-training is required.Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE-mediated symptoms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usually mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food challenges are usually not necessary but may be used to confirm or refute a conflicting history and test result. As nut allergy is likely to be a long-lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehensive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medication. Regular re-training is required. Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE-mediated symptoms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usually mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food challenges are usually not necessary but may be used to confirm or refute a conflicting history and test result. As nut allergy is likely to be a long-lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehensive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medication. Regular re-training is required. |
| Author | Luyt, D. Clark, A. T. Venter, C. Anagnostou, K. Boyle, R. J. Stiefel, G. Huber, P. Brathwaite, N. Till, S. J. Ewan, P. Fox, A. T. |
| Author_xml | – sequence: 1 givenname: G. surname: Stiefel fullname: Stiefel, G. organization: Leicester Royal Infirmary – sequence: 2 givenname: K. surname: Anagnostou fullname: Anagnostou, K. organization: Guy's and St Thomas’ NHS Foundation Trust – sequence: 3 givenname: R. J. surname: Boyle fullname: Boyle, R. J. organization: Imperial College London – sequence: 4 givenname: N. surname: Brathwaite fullname: Brathwaite, N. organization: King's College Hospital NHS Foundation Trust – sequence: 5 givenname: P. surname: Ewan fullname: Ewan, P. organization: Addenbrooke's Hospital – sequence: 6 givenname: A. T. surname: Fox fullname: Fox, A. T. organization: Guy's and St Thomas’ NHS Foundation Trust – sequence: 7 givenname: P. orcidid: 0000-0001-9823-7863 surname: Huber fullname: Huber, P. organization: British Society for Allergy and Clinical Immunology – sequence: 8 givenname: D. surname: Luyt fullname: Luyt, D. organization: Leicester Royal Infirmary – sequence: 9 givenname: S. J. surname: Till fullname: Till, S. J. organization: King's College Hospital NHS Foundation Trust – sequence: 10 givenname: C. surname: Venter fullname: Venter, C. organization: St. Mary's Hospital – sequence: 11 givenname: A. T. surname: Clark fullname: Clark, A. T. email: Andrew.clark@addenbrookes.nhs.uk organization: Addenbrooke's Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28836701$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90UtLAzEQB_Agin3owS8gAS962DaPTTc51lK1UOhBPS_p7mxN2U1qsov027t96KGgcwkhvxmG_Hvo3DoLCN1QMqBtDTPQA8qUSM5Ql_KRiFhb56hLlIijRKq4g3ohrAkhXCh5iTpMSj5KCO2ixePreDLDq8bkUBoLuHAe1x-Ac6NX1gUTsLY5rrTVK6jA1tgVeAPaNvX-ofYAeH8pS_Cr7RW6KHQZ4Pp49tH70_Rt8hLNF8-zyXgeZTFVSbRkkhQ5SCI0iQnRLMkZFYQz4Bo052K0LHKqJM9ASC5ELEBRLkjBY5JImvM-uj_M3Xj32UCo08qEDMpSW3BNSKnijI4US2RL707o2jXettu1isSJ4krt1O1RNcsK8nTjTaX9Nv35qhY8HEDmXQgeil9CSbqLIW1jSPcxtHZ4YjNT69o4W3ttyv86vkwJ279Hp5Pp-NDxDaGwlP8 |
| CitedBy_id | crossref_primary_10_1002_mnfr_202300134 crossref_primary_10_1016_j_jaip_2024_07_030 crossref_primary_10_1111_1753_6405_13241 crossref_primary_10_3390_nu11020359 crossref_primary_10_3390_children10030585 crossref_primary_10_1016_j_anai_2018_09_466 crossref_primary_10_3389_falgy_2023_1270344 crossref_primary_10_1080_1744666X_2023_2159812 crossref_primary_10_1007_s11882_018_0831_5 crossref_primary_10_1111_pai_13705 crossref_primary_10_1111_cea_14549 crossref_primary_10_1016_j_aller_2019_07_005 crossref_primary_10_7748_ncyp_2019_e1097 crossref_primary_10_1016_j_anai_2023_02_004 crossref_primary_10_1016_j_anai_2017_12_014 crossref_primary_10_2147_JAA_S335265 crossref_primary_10_1080_10408398_2022_2045897 crossref_primary_10_12956_tchd_840929 crossref_primary_10_1136_dtb_2022_000044 crossref_primary_10_1016_j_jfoodeng_2024_112378 crossref_primary_10_3390_nu13082578 crossref_primary_10_1007_s40521_022_00320_7 crossref_primary_10_1111_cea_13327 crossref_primary_10_1016_j_waojou_2021_100550 crossref_primary_10_1111_cea_12991 crossref_primary_10_1016_j_molimm_2018_03_015 crossref_primary_10_1111_cea_13163 crossref_primary_10_1016_j_jaip_2021_05_035 crossref_primary_10_1111_cea_14491 crossref_primary_10_3390_medicina55100651 crossref_primary_10_1016_j_alit_2021_07_006 crossref_primary_10_1016_j_anai_2020_01_024 crossref_primary_10_1007_s12016_021_08895_w crossref_primary_10_3389_fimmu_2021_742732 crossref_primary_10_1002_psb_1928 crossref_primary_10_1007_s00604_023_06146_7 crossref_primary_10_1111_cea_13395 crossref_primary_10_24323_akademik_gida_818202 crossref_primary_10_3390_nu16233978 crossref_primary_10_1016_j_foodchem_2020_126192 crossref_primary_10_1016_j_jaci_2021_10_018 crossref_primary_10_1016_j_anai_2019_02_005 crossref_primary_10_1007_s15007_021_4931_5 crossref_primary_10_1016_j_foodres_2020_109597 crossref_primary_10_1016_j_jaci_2019_06_038 crossref_primary_10_1007_s40521_021_00290_2 crossref_primary_10_1016_S0140_6736_19_30767_6 crossref_primary_10_3390_medicina55080498 crossref_primary_10_3388_jspaci_37_99 crossref_primary_10_1016_j_iac_2019_07_004 crossref_primary_10_1016_j_reval_2020_03_004 crossref_primary_10_3390_medicina57010067 crossref_primary_10_1007_s00394_024_03358_2 crossref_primary_10_1016_j_anai_2022_07_033 crossref_primary_10_1016_j_reval_2018_09_005 crossref_primary_10_1097_ACI_0000000000000900 crossref_primary_10_1097_NT_0000000000000596 crossref_primary_10_1016_j_reval_2020_09_024 crossref_primary_10_1111_cea_14103 crossref_primary_10_1016_j_jaip_2023_01_049 crossref_primary_10_1371_journal_pone_0241648 crossref_primary_10_1111_pai_13215 crossref_primary_10_1111_pai_13852 crossref_primary_10_1111_pai_13854 crossref_primary_10_1016_j_jaip_2022_02_023 crossref_primary_10_1007_s40629_021_00190_6 crossref_primary_10_1159_000539324 crossref_primary_10_1016_j_waojou_2020_100491 crossref_primary_10_1016_j_jaci_2020_11_004 crossref_primary_10_1002_clt2_12213 crossref_primary_10_3349_ymj_2019_60_10_960 crossref_primary_10_1097_ACI_0000000000000999 crossref_primary_10_1111_cea_12950 crossref_primary_10_1111_cea_13368 crossref_primary_10_1111_cea_13087 crossref_primary_10_1111_jpc_16398 crossref_primary_10_1016_j_reval_2021_01_008 crossref_primary_10_1016_j_jaci_2018_10_050 crossref_primary_10_1111_pai_12959 crossref_primary_10_1111_all_16404 crossref_primary_10_3399_bjgp18X694817 crossref_primary_10_3390_nu13020640 crossref_primary_10_1007_s42399_022_01285_z crossref_primary_10_1136_bcr_2022_252602 crossref_primary_10_1111_cea_14208 crossref_primary_10_26416_Aler_2_4_2018_2130 crossref_primary_10_1111_cea_13115 crossref_primary_10_1016_j_jaip_2020_09_064 crossref_primary_10_5005_jp_journals_10070_8016 crossref_primary_10_1111_cea_13234 crossref_primary_10_1177_0018578718797266 crossref_primary_10_1136_jclinpath_2020_206994 crossref_primary_10_3389_fped_2020_00113 crossref_primary_10_1111_cea_13073 crossref_primary_10_1136_bmjopen_2023_074168 crossref_primary_10_3934_medsci_2017_4_441 crossref_primary_10_1016_j_reval_2022_03_006 crossref_primary_10_3390_nu13114076 crossref_primary_10_3390_nu15245132 crossref_primary_10_1111_cea_13187 crossref_primary_10_1111_cea_13341 crossref_primary_10_1111_1541_4337_70098 |
| Cites_doi | 10.1111/all.12820 10.1016/j.jaci.2014.11.034 10.1111/j.1399-3038.2007.00517.x 10.1111/all.12671 10.1016/0091-6749(84)90083-6 10.1111/j.1398-9995.2011.02754.x 10.1067/mai.2003.1517 10.1046/j.1365-2222.2003.01795.x 10.1016/j.jaci.2013.03.043 10.1111/j.1365-2222.2009.03312.x 10.1111/all.12424 10.1046/j.1365-2745.2003.01624.x 10.1016/j.jaci.2015.01.002 10.1136/bmj.313.7056.514 10.1016/j.jaci.2014.09.001 10.1111/all.12628 10.1111/cea.12466 10.1111/j.1398-9995.2010.02343.x 10.1067/mai.2003.1486 10.1067/mai.2002.124775 10.1111/j.1365-2222.2011.03699.x 10.1186/2045-7022-4-30 10.1046/j.1365-2222.2003.01671.x 10.1111/cea.12788 10.1034/j.1399-3038.2003.00072.x 10.1111/j.1399-3038.2011.01191.x 10.1056/NEJMoa013536 10.1016/j.jaci.2015.03.037 10.1016/j.jaci.2006.04.024 10.1111/j.1398-9995.2008.01843.x 10.1111/j.1399-3038.2007.00519.x 10.1111/j.1398-9995.2009.01982.x 10.1034/j.1398-9995.1999.00768.x 10.1016/j.jaci.2009.05.022 10.1111/j.1398-9995.2009.02176.x 10.1016/S0091-6749(99)70224-1 10.1016/j.jaci.2014.10.021 10.1016/j.jaci.2013.02.034 10.1016/j.jaci.2007.05.026 10.1016/j.jaip.2012.08.007 10.1111/all.12924 10.1111/cea.12693 10.1016/j.jaci.2005.09.002 10.1111/cea.12267 10.1111/j.1365-2222.2011.03912.x 10.1034/j.1398-9995.2001.056003252.x 10.1111/j.1399-3038.2009.00887.x 10.1542/peds.102.1.e6 10.1016/j.jaci.2012.05.019 10.1111/all.12530 10.1016/j.jaci.2005.11.035 10.1111/j.1399-3038.2009.00975.x 10.1016/j.jaip.2013.05.008 10.1007/s00431-016-2733-7 10.1016/j.jaci.2010.02.009 10.1542/peds.101.3.e8 10.1067/mai.2001.112129 10.1016/j.jaci.2010.04.030 10.1016/j.jaci.2010.01.057 10.1016/j.jaci.2010.12.1083 10.1016/j.jaci.2008.04.014 10.1016/j.jaip.2012.11.002 10.1111/j.1365-2222.2007.02764.x 10.1067/mai.2000.103052 10.1111/pai.12563 10.1111/j.1398-9995.2005.00909.x 10.3399/bjgp17X689917 10.1111/pai.12554 10.1111/apa.12687 10.1136/adc.85.4.348b 10.1111/j.1399-3038.2012.01310.x 10.1016/j.jaci.2008.05.028 10.1136/bmj.312.7038.1074 10.1111/j.1399-3038.2010.01043.x 10.1111/pai.12610 10.1016/j.jaci.2007.01.021 10.1111/j.1398-9995.2007.01570.x 10.1097/WOX.0b013e318211496c 10.1046/j.1365-2222.2000.00928.x 10.1016/j.jaci.2013.02.024 10.1016/S0140-6736(08)60659-5 10.1016/j.jaci.2008.12.014 10.1111/cea.12406 10.1056/NEJMoa1514210 10.1016/j.jaci.2010.03.029 10.1016/j.jaci.2012.09.015 10.1111/pai.12564 10.1016/j.jaci.2008.04.032 10.3399/bjgp11X583498 10.1016/S1081-1206(10)61994-1 10.1111/cea.12136 10.1111/all.12956 10.1016/j.jaci.2004.07.063 10.1046/j.1365-2222.2000.00960.x 10.1016/j.anai.2015.05.015 10.1111/all.12437 10.1016/j.jaci.2011.01.039 10.1111/pai.12048 10.1111/j.1399-3038.2011.01264.x 10.1111/pai.12107 10.1016/S1081-1206(10)61869-8 10.1016/j.jaci.2009.10.008 10.1067/mai.2001.115755 10.1111/j.1399-3038.2005.00251.x 10.1016/j.jaci.2013.05.038 10.1016/j.jaci.2007.07.015 10.1111/j.1399-3038.2006.00392.x 10.1111/j.1399-3038.2010.01063.x 10.1016/j.jaip.2015.12.012 10.1016/j.jaci.2010.12.012 10.1111/pai.12337 10.1111/all.13050 10.1016/j.jaci.2007.12.003 10.1016/j.jaci.2010.12.004 10.1016/j.jaci.2005.05.047 10.1016/j.jaci.2012.01.056 10.1136/bmj.e896 10.1016/j.jaci.2006.12.670 10.1046/j.1398-9995.2003.00300.x 10.1016/j.jaci.2006.03.029 10.1067/mai.2001.119157 10.1111/cea.12477 10.1111/j.1398-9995.2004.00466.x 10.1111/j.1399-3038.2005.00305.x 10.1111/all.12075 10.1046/j.1398-9995.2003.00342.x 10.1016/j.jaci.2008.05.015 10.1111/j.1399-3038.2012.01332.x 10.1016/j.jaci.2014.03.035 10.1002/0470861193.ch10 10.1016/j.jaci.2011.01.031 10.1111/j.1365-2222.2008.02998.x 10.1186/1710-1492-4-4-144 10.1016/j.jaci.2008.08.039 10.1067/mpd.2000.109376 10.1016/j.jaci.2009.03.050 10.1016/j.jaci.2007.11.024 10.1016/S0091-6749(97)70133-7 10.1111/pai.12261 10.1016/S1081-1206(10)61187-8 10.1111/j.1399-3038.2010.01088.x 10.1056/NEJMoa1414850 10.1111/j.1651-2227.2005.tb01966.x 10.1111/j.1398-9995.2011.02766.x 10.1016/j.jaci.2014.12.1053 10.1111/j.1365-2222.2011.03717.x 10.1111/j.1399-3038.2005.00310.x |
| ContentType | Journal Article |
| Copyright | 2017 John Wiley & Sons Ltd 2017 John Wiley & Sons Ltd. Copyright © 2017 John Wiley & Sons Ltd |
| Copyright_xml | – notice: 2017 John Wiley & Sons Ltd – notice: 2017 John Wiley & Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons Ltd |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 |
| DOI | 10.1111/cea.12957 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1365-2222 |
| EndPage | 739 |
| ExternalDocumentID | 28836701 10_1111_cea_12957 CEA12957 |
| Genre | article Journal Article Practice Guideline |
| GrantInformation_xml | – fundername: Medical Research Council grantid: G1000758 |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 29B 31~ 33P 36B 3O- 3SF 4.4 4P2 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBB EBC EBD EBS EBX EDH EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 ESTFP |
| ID | FETCH-LOGICAL-c4197-b280fde805a0400a27d215032e3aea3356bfd1983ce5835545e91350f340781d3 |
| IEDL.DBID | DR2 |
| ISSN | 0954-7894 1365-2222 |
| IngestDate | Mon Sep 08 13:19:25 EDT 2025 Sun Jul 13 05:17:42 EDT 2025 Mon Jul 21 06:04:00 EDT 2025 Tue Jul 01 02:53:27 EDT 2025 Thu Apr 24 23:02:42 EDT 2025 Wed Jan 22 16:26:46 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | hazelnut pecan pistachio pollen food syndrome macadamia almond diagnosis epicutaneous immunotherapy anaphylaxis epinephrine tree nut food sublingual walnut macadamia food allergy adrenaline management Brazil aetiology oral allergy syndrome cashew oral peanut |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4197-b280fde805a0400a27d215032e3aea3356bfd1983ce5835545e91350f340781d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| ORCID | 0000-0001-9823-7863 |
| PMID | 28836701 |
| PQID | 1904793998 |
| PQPubID | 36521 |
| PageCount | 21 |
| ParticipantIDs | proquest_miscellaneous_1932169278 proquest_journals_1904793998 pubmed_primary_28836701 crossref_primary_10_1111_cea_12957 crossref_citationtrail_10_1111_cea_12957 wiley_primary_10_1111_cea_12957_CEA12957 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2017 2017-06-00 2017-Jun 20170601 |
| PublicationDateYYYYMMDD | 2017-06-01 |
| PublicationDate_xml | – month: 06 year: 2017 text: June 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | Clinical and experimental allergy |
| PublicationTitleAlternate | Clin Exp Allergy |
| PublicationYear | 2017 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2013; 1 2015; 70 2013; 68 2000; 137 2008; 38 2011; 61 2003; 58 2014; 25 2005; 60 2012; 129 2014; 134 2011; 127 2015; 372 2010; 21 2012; 130 2015; 135 2015; 136 2000; 10 2002; 88 2009; 123 2009; 124 1999; 54 2001; 56 2012; 23 2016; 46 2007; 18 2009; 64 2012; 344 2005; 115 2005; 116 2017; 67 1999; 103 2011; 4 2008; 122 2008; 121 2006; 118 2006; 117 2014; 45 2014; 44 2003; 33 2016; 4 2003; 348 2015; 115 2000; 105 2004; 59 2005; 95 2005; 94 2005; 16 2016; 27 2016; 175 2012; 42 2008; 371 2013; 24 2003; 14 2014; 69 2016; 72 2016; 71 2008; 4 2001; 108 2001; 107 2003; 112 2001; 85 2007; 37 2015; 45 2010; 65 2003; 90 2014; 4 1997; 100 2011; 22 2008; 63 2002; 109 2012; 67 2009; 20 2013; 43 2010; 125 2006; 17 2010; 126 2007; 120 2006 2015; 26 1984; 74 2007; 119 2004; 114 2000; 30 2011; 41 2016; 374 2015 2013; 132 2014 2013; 131 2013 1996; 313 1996; 312 1998; 102 1998; 101 2014; 103 2009; 39 e_1_2_18_142_1 e_1_2_18_60_1 e_1_2_18_22_1 e_1_2_18_45_1 e_1_2_18_68_1 e_1_2_18_41_1 e_1_2_18_64_1 e_1_2_18_5_1 e_1_2_18_83_1 e_1_2_18_9_1 e_1_2_18_112_1 e_1_2_18_135_1 e_1_2_18_26_1 e_1_2_18_49_1 e_1_2_18_87_1 e_1_2_18_139_1 e_1_2_18_90_1 e_1_2_18_130_1 e_1_2_18_153_1 e_1_2_18_71_1 e_1_2_18_10_1 e_1_2_18_33_1 e_1_2_18_56_1 e_1_2_18_79_1 e_1_2_18_108_1 e_1_2_18_52_1 e_1_2_18_75_1 e_1_2_18_94_1 e_1_2_18_100_1 e_1_2_18_123_1 e_1_2_18_146_1 e_1_2_18_18_1 e_1_2_18_14_1 e_1_2_18_37_1 e_1_2_18_98_1 e_1_2_18_104_1 e_1_2_18_127_1 e_1_2_18_82_1 e_1_2_18_141_1 Faire A (e_1_2_18_147_1) 2013; 43 e_1_2_18_119_1 e_1_2_18_21_1 e_1_2_18_67_1 e_1_2_18_4_1 e_1_2_18_44_1 e_1_2_18_63_1 e_1_2_18_8_1 e_1_2_18_40_1 e_1_2_18_111_1 e_1_2_18_134_1 e_1_2_18_29_1 e_1_2_18_86_1 e_1_2_18_115_1 e_1_2_18_138_1 e_1_2_18_25_1 e_1_2_18_48_1 e_1_2_18_93_1 e_1_2_18_110_1 e_1_2_18_152_1 e_1_2_18_70_1 e_1_2_18_32_1 e_1_2_18_78_1 e_1_2_18_13_1 e_1_2_18_55_1 e_1_2_18_74_1 e_1_2_18_51_1 e_1_2_18_122_1 e_1_2_18_97_1 e_1_2_18_103_1 e_1_2_18_145_1 e_1_2_18_36_1 e_1_2_18_17_1 e_1_2_18_59_1 e_1_2_18_107_1 e_1_2_18_149_1 e_1_2_18_81_1 e_1_2_18_121_1 e_1_2_18_140_1 e_1_2_18_24_1 e_1_2_18_43_1 e_1_2_18_66_1 e_1_2_18_3_1 e_1_2_18_20_1 e_1_2_18_62_1 e_1_2_18_7_1 e_1_2_18_133_1 e_1_2_18_85_1 e_1_2_18_114_1 e_1_2_18_156_1 e_1_2_18_28_1 e_1_2_18_47_1 e_1_2_18_89_1 e_1_2_18_118_1 e_1_2_18_92_1 e_1_2_18_132_1 e_1_2_18_151_1 e_1_2_18_12_1 e_1_2_18_35_1 e_1_2_18_54_1 e_1_2_18_77_1 e_1_2_18_31_1 e_1_2_18_50_1 e_1_2_18_73_1 RCPCH (e_1_2_18_137_1) 2006 e_1_2_18_96_1 e_1_2_18_102_1 e_1_2_18_125_1 e_1_2_18_144_1 Food Standard Agency (e_1_2_18_116_1) 2015 e_1_2_18_39_1 e_1_2_18_58_1 e_1_2_18_106_1 e_1_2_18_129_1 e_1_2_18_148_1 e_1_2_18_16_1 e_1_2_18_80_1 e_1_2_18_143_1 e_1_2_18_120_1 e_1_2_18_2_1 e_1_2_18_46_1 Garcia F (e_1_2_18_126_1) 2000; 10 e_1_2_18_23_1 e_1_2_18_65_1 e_1_2_18_6_1 e_1_2_18_42_1 e_1_2_18_61_1 e_1_2_18_84_1 e_1_2_18_113_1 e_1_2_18_136_1 e_1_2_18_155_1 e_1_2_18_88_1 e_1_2_18_27_1 e_1_2_18_69_1 e_1_2_18_150_1 British Retail Consortium 2 (e_1_2_18_117_1) 2013 e_1_2_18_91_1 e_1_2_18_154_1 e_1_2_18_131_1 e_1_2_18_11_1 e_1_2_18_57_1 e_1_2_18_109_1 e_1_2_18_34_1 e_1_2_18_76_1 e_1_2_18_53_1 e_1_2_18_30_1 e_1_2_18_72_1 e_1_2_18_19_1 e_1_2_18_95_1 e_1_2_18_101_1 e_1_2_18_124_1 e_1_2_18_15_1 e_1_2_18_99_1 e_1_2_18_105_1 e_1_2_18_38_1 e_1_2_18_128_1 28763130 - Clin Exp Allergy. 2017 Sep;47(9):1223-1224. doi: 10.1111/cea.12991. |
| References_xml | – volume: 108 start-page: 867 year: 2001 end-page: 70 article-title: Peanut and tree nut allergic reactions in restaurants and other food establishments publication-title: J Allergy Clin Immunol – volume: 30 start-page: 1495 year: 2000 end-page: 8 article-title: Food allergy–getting more out of your skin prick tests publication-title: Clin Exp Allergy – volume: 374 start-page: 1733 year: 2016 end-page: 43 article-title: Randomized trial of introduction of allergenic foods in breast‐fed infants publication-title: N Engl J Med – volume: 88 start-page: 183 year: 2002 end-page: 9 article-title: Prevalence of food allergies in young adults and their relationship to asthma, nasal allergies, and eczema publication-title: Ann Allergy Asthma Immunol – volume: 127 start-page: 661 year: 2011 end-page: 7 article-title: Loss‐of‐function variants in the filaggrin gene are a significant risk factor for peanut allergy publication-title: J Allergy Clin Immunol – volume: 4 start-page: 13 year: 2011 end-page: 37 article-title: World allergy organization guidelines for the assessment and management of anaphylaxis publication-title: World Allergy Organ J – volume: 21 start-page: 586 year: 2010 end-page: 94 article-title: Management of nut allergy influences quality of life and anxiety in children and their mothers publication-title: Pediatr Allergy Immunol – volume: 46 start-page: 1258 year: 2016 end-page: 80 article-title: BSACI guideline: prescribing an adrenaline auto‐injector publication-title: Clin Exp Allergy – volume: 132 start-page: 239 year: 2013 end-page: 42 article-title: Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status publication-title: J Allergy Clin Immunol – volume: 105 start-page: 577 year: 2000 end-page: 81 article-title: Hazelnut allergy: a double‐blind, placebo‐controlled food challenge multicenter study publication-title: J Allergy Clin Immunol – volume: 23 start-page: 205 year: 2012 end-page: 6 article-title: Tree nut introduction in peanut allergic children is not without risk publication-title: Pediatr Allergy Immunol – year: 2014 – volume: 63 start-page: 354 year: 2008 end-page: 9 article-title: Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life publication-title: Allergy – volume: 24 start-page: 173 year: 2013 end-page: 7 article-title: A randomized maternal evaluation of epinephrine autoinjection devices publication-title: Pediatr Allergy Immunol – volume: 101 start-page: E8 year: 1998 article-title: Prevalence of IgE‐mediated food allergy among children with atopic dermatitis publication-title: Pediatrics – volume: 132 start-page: 393 year: 2013 end-page: 9 article-title: Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults publication-title: J Allergy Clin Immunol – volume: 22 start-page: 196 issue: 2 year: 2011 end-page: 201 article-title: Young infants with atopic dermatitis can display sensitization to Cor a 9, an 11S legumin‐like seed‐storage protein from hazelnut ( ) publication-title: Pediatr Allergy Immunol – volume: 135 start-page: 1257 year: 2015 end-page: 66 article-title: Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population‐based assessment publication-title: J Allergy Clin Immunol – volume: 312 start-page: 1074 year: 1996 end-page: 8 article-title: Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations publication-title: BMJ – volume: 124 start-page: 301 year: 2009 end-page: 6 article-title: Anaphylaxis in the community: learning from the survivors publication-title: J Allergy Clin Immunol – volume: 71 start-page: 1762 year: 2016 end-page: 71 article-title: Introduction of peanuts in younger siblings of children with peanut allergy: a prospective, double‐blinded assessment of risk, of diagnostic tests, and an analysis of patient preferences publication-title: Allergy – volume: 116 start-page: 884 year: 2005 end-page: 92 article-title: Prevalence of sensitization to food allergens, reported adverse reaction to foods, food avoidance, and food hypersensitivity among teenagers publication-title: J Allergy Clin Immunol – volume: 65 start-page: 103 year: 2010 end-page: 8 article-title: Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK publication-title: Allergy – volume: 136 start-page: 192 year: 2015 end-page: 4 article-title: Sensitization to cashew nut 2S albumin, Ana o 3, is highly predictive of cashew and pistachio allergy in Greek children publication-title: J Allergy Clin Immunol – volume: 41 start-page: 994 year: 2011 end-page: 1000 article-title: Skin prick testing and peanut‐specific IgE can predict peanut challenge outcomes in preschoolchildren with peanut sensitization publication-title: Clin Exp Allergy – volume: 46 start-page: 654 year: 2016 end-page: 6 article-title: Specific IgE to recombinant protein (Ber e 1) for the diagnosis of Brazil nut allergy publication-title: Clin Exp Allergy – volume: 65 start-page: 681 year: 2010 end-page: 9 article-title: The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school publication-title: Allergy – volume: 125 start-page: 191 year: 2010 end-page: 7 article-title: Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component‐resolved diagnostics publication-title: J Allergy Clin Immunol – volume: 119 start-page: 1018 year: 2007 end-page: 9 article-title: Further fatal allergic reactions to food in the United Kingdom, 1999–2006 publication-title: J Allergy Clin Immunol – volume: 70 start-page: 90 year: 2015 end-page: 8 article-title: Predictive values of component‐specific IgE for the outcome of peanut and hazelnut food challenges in children publication-title: Allergy – volume: 109 start-page: 1027 year: 2002 end-page: 33 article-title: Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays publication-title: J Allergy Clin Immunol – volume: 18 start-page: 224 year: 2007 end-page: 30 article-title: Skin prick testing predicts peanut challenge outcome in previously allergic or sensitized children with low serum peanut‐specific IgE antibody concentration publication-title: Pediatr Allergy Immunol – volume: 100 start-page: 444 year: 1997 end-page: 51 article-title: Relationship between food‐specific IgE concentrations and the risk of positive food challenges in children and adolescents publication-title: J Allergy Clin Immunol – volume: 39 start-page: 1427 year: 2009 end-page: 37 article-title: The non‐specific lipid transfer protein, Ara h 9, is an important allergen in peanut publication-title: Clin Exp Allergy – volume: 41 start-page: 1273 year: 2011 end-page: 81 article-title: Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcome publication-title: Clin Exp Allergy – volume: 125 start-page: 1322 year: 2010 end-page: 6 article-title: US prevalence of self‐reported peanut, tree nut, and sesame allergy: 11‐year follow‐up publication-title: J Allergy Clin Immunol – volume: 69 start-page: 1026 year: 2014 end-page: 45 article-title: Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology publication-title: Allergy – volume: 70 start-page: 855 year: 2015 end-page: 63 article-title: Patients’ ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial publication-title: Allergy – volume: 120 start-page: 638 year: 2007 end-page: 46 article-title: The prevalence of food allergy: a meta‐analysis publication-title: J Allergy Clin Immunol – volume: 120 start-page: 491 year: 2007 end-page: 503 article-title: Peanut allergy: emerging concepts and approaches for an apparent epidemic publication-title: J Allergy Clin Immunol – volume: 127 start-page: 640 year: 2011 end-page: 6 article-title: Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization publication-title: J Allergy Clin Immunol – volume: 114 start-page: 1164 year: 2004 end-page: 8 article-title: Risk of oral food challenges publication-title: J Allergy Clin Immunol – volume: 132 start-page: 874 year: 2013 end-page: 80 article-title: Skin prick test responses and allergen‐specific IgE levels as predictors of peanut, egg, and sesame allergy in infants publication-title: J Allergy Clin Immunol – volume: 1 start-page: 101 year: 2013 end-page: 3 article-title: Evaluation of Ara h2 IgE thresholds in the diagnosis of peanut allergy in a clinical population publication-title: J Allergy Clin Immunol Pract – volume: 30 start-page: 1540 year: 2000 end-page: 6 article-title: Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children publication-title: Clin Exp Allergy – volume: 25 start-page: 462 year: 2014 end-page: 7 article-title: Comparison of adrenaline auto‐injector devices: ease of use and ability to recall use publication-title: Pediatr Allergy Immunol – volume: 18 start-page: 231 year: 2007 end-page: 9 article-title: Combining skin prick, immediate skin application and specific‐IgE testing in the diagnosis of peanut allergy in children publication-title: Pediatr Allergy Immunol – volume: 21 start-page: 603 year: 2010 end-page: 11 article-title: Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level publication-title: Pediatr Allergy Immunol – volume: 10 start-page: 173 year: 2000 end-page: 7 article-title: Allergy to Anacardiaceae: description of cashew and pistachio nut allergens publication-title: J Investig Allergol Clin Immunol – volume: 115 start-page: 1291 year: 2005 end-page: 6 article-title: Diagnosing peanut allergy with skin prick and specific IgE testing publication-title: J Allergy Clin Immunol – volume: 371 start-page: 1538 year: 2008 end-page: 46 article-title: Peanut allergy publication-title: Lancet – volume: 33 start-page: 1041 year: 2003 end-page: 5 article-title: Interpretation of tests for nut allergy in one thousand patients, in relation to allergy or tolerance publication-title: Clin Exp Allergy – volume: 112 start-page: 180 year: 2003 end-page: 2 article-title: Relevance of casual contact with peanut butter in children with peanut allergy publication-title: J Allergy Clin Immunol – volume: 54 start-page: 380 year: 1999 end-page: 5 article-title: Perceived prevalence of peanut allergy in Great Britain and its association with other atopic conditions and with peanut allergy in other household members publication-title: Allergy – volume: 17 start-page: 227 year: 2006 end-page: 9 article-title: Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic children publication-title: Pediatr Allergy Immunol – volume: 43 start-page: 1462 year: 2013 article-title: Behaviours towards siblings of children with nut allergy; how might these influence management? publication-title: Clin Exp Allergy – volume: 137 start-page: 749 year: 2000 end-page: 55 article-title: The natural history of peanut allergy in young children and its association with serum peanut‐specific IgE publication-title: J Pediatr – volume: 135 start-page: 956 year: 2015 end-page: 63 article-title: Increase in anaphylaxis‐related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012 publication-title: J Allergy Clin Immunol – volume: 175 start-page: 1227 year: 2016 end-page: 34 article-title: Mono‐sensitisation to peanut component Ara h 6: a case series of five children and literature review publication-title: Eur J Pediatr – volume: 68 start-page: 190 year: 2013 end-page: 4 article-title: Clinical value of component‐resolved diagnostics in peanut‐allergic patients publication-title: Allergy – volume: 16 start-page: 507 year: 2005 end-page: 11 article-title: The development and progression of allergy to multiple nuts at different ages publication-title: Pediatr Allergy Immunol – volume: 112 start-page: 183 year: 2003 end-page: 9 article-title: The natural progression of peanut allergy: resolution and the possibility of recurrence publication-title: J Allergy Clin Immunol – volume: 118 start-page: 466 year: 2006 end-page: 72 article-title: Accidental ingestions in children with peanut allergy publication-title: J Allergy Clin Immunol – volume: 1 start-page: 528 year: 2013 end-page: 30 article-title: Natural resolution of peanut allergy: a 12‐year longitudinal follow‐up study publication-title: J Allergy Clin Immunol Pract – volume: 4 start-page: 30 year: 2014 article-title: Peanut immunotherapy publication-title: Clin Transl Allergy – volume: 1 start-page: 75 year: 2013 end-page: 82 article-title: The utility of peanut components in the diagnosis of IgE‐mediated peanut allergy among distinct populations publication-title: J Allergy Clin Immunol Pract – year: 2013 – volume: 67 start-page: e300 year: 2017 end-page: 5 article-title: Prescription rates of adrenaline auto‐injectors for children in UK general practice: a retrospective cohort study publication-title: Br J Gen Pract – volume: 126 start-page: 83 year: 2010 end-page: 91 article-title: Oral peanut immunotherapy in children with peanut anaphylaxis publication-title: J Allergy Clin Immunol – volume: 94 start-page: 689 year: 2005 end-page: 95 article-title: Severe food‐allergic reactions in children across the UK and Ireland, 1998‐2000 publication-title: Acta Paediatr – volume: 124 start-page: 292 year: 2009 end-page: 300 article-title: Clinical efficacy and immune regulation with peanut oral immunotherapy publication-title: J Allergy Clin Immunol – volume: 23 start-page: 412 year: 2012 end-page: 9 article-title: Parent perceived quality of life is age‐dependent in children with food allergy publication-title: Pediatr Allergy Immunol – volume: 56 start-page: 252 year: 2001 end-page: 3 article-title: Clinical features of cashew allergy publication-title: Allergy – volume: 125 start-page: 1391 year: 2010 end-page: 2 article-title: Utility of peanut‐specific IgE levels in predicting the outcome of double‐blind, placebo‐controlled food challenges publication-title: J Allergy Clin Immunol – volume: 372 start-page: 803 year: 2015 end-page: 13 article-title: Randomized trial of peanut consumption in infants at risk for peanut allergy publication-title: N Engl J Med – volume: 95 start-page: 45 year: 2005 end-page: 52 article-title: Cross‐reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific igE serologic surveys publication-title: Ann Allergy Asthma Immunol – volume: 107 start-page: 367 year: 2001 end-page: 74 article-title: The natural history of peanut allergy publication-title: J Allergy Clin Immunol – volume: 44 start-page: 319 year: 2014 end-page: 41 article-title: Walnut allergens: molecular characterization, detection and clinical relevance publication-title: Clin Exp Allergy – volume: 38 start-page: 1229 year: 2008 end-page: 38 article-title: Pistachio vicilin, Pis v 3, is immunoglobulin E‐reactive and cross‐reacts with the homologous cashew allergen, Ana o 1 publication-title: Clin Exp Allergy – volume: 125 start-page: 1098 year: 2010 end-page: 104 article-title: Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review publication-title: J Allergy Clin Immunol – volume: 45 start-page: 255 year: 2015 end-page: 64 article-title: Which infants with eczema are at risk of food allergy? Results from a population‐based cohort publication-title: Clin Exp Allergy – volume: 117 start-page: 1440 year: 2006 end-page: 5 article-title: Risk‐taking and coping strategies of adolescents and young adults with food allergy publication-title: J Allergy Clin Immunol – volume: 45 start-page: 859 year: 2014 end-page: 71 article-title: Dietary management of peanut and tree nut allergy: what exactly should patients avoid? publication-title: Clin Exp Allergy – volume: 43 start-page: 967 year: 2013 end-page: 74 article-title: IgE binding to peanut components by four different techniques: Ara h 2 is the most relevant in peanut allergic children and adults publication-title: Clin Exp Allergy – volume: 103 start-page: 559 year: 1999 end-page: 62 article-title: Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey publication-title: J Allergy Clin Immunol – volume: 37 start-page: 1221 year: 2007 end-page: 8 article-title: Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time publication-title: Clin Exp Allergy – volume: 58 start-page: 1311 year: 2003 end-page: 4 article-title: Cashew allergy: observations of 42 children without associated peanut allergy publication-title: Allergy – volume: 26 start-page: 126 year: 2015 end-page: 32 article-title: Health‐related quality of life in children with perceived and diagnosed food hypersensitivity publication-title: Pediatr Allergy Immunol – volume: 116 start-page: 1087 year: 2005 end-page: 93 article-title: The natural history of tree nut allergy publication-title: J Allergy Clin Immunol – volume: 85 start-page: 348 year: 2001 article-title: Age specific aetiology of anaphylaxis publication-title: Arch Dis Child – volume: 117 start-page: 448 year: 2006 end-page: 54 article-title: Determination of no‐observed‐adverse‐effect levels and eliciting doses in a representative group of peanut‐sensitized children publication-title: J Allergy Clin Immunol – volume: 4 start-page: 265 year: 2016 end-page: 72 article-title: Cor a 14, Hazelnut‐specific IgE, and SPT as a reliable tool in hazelnut allergy diagnosis in Eastern Mediterranean children publication-title: J Allergy Clin Immunol Pract – volume: 348 start-page: 977 year: 2003 end-page: 85 article-title: Factors associated with the development of peanut allergy in childhood publication-title: N Engl J Med – volume: 135 start-page: AB38 year: 2015 article-title: Prevalence of sensitisation to food and aero‐allergens and challenge proven food allergy amongst 11‐year‐old children on the Isle of Wight publication-title: J Allergy Clin Immunol – volume: 4 start-page: 144 year: 2008 end-page: 9 article-title: Should younger siblings of peanut‐allergic children be assessed by an allergist before being fed peanut? publication-title: Allergy Asthma Clin Immunol – volume: 130 start-page: 468 year: 2012 end-page: 72 article-title: Peanut component Ara h 8 sensitization and tolerance to peanut publication-title: J Allergy Clin Immunol – volume: 102 start-page: e6 year: 1998 article-title: Clinical features of acute allergic reactions to peanut and tree nuts in children publication-title: Pediatrics – volume: 42 start-page: 284 year: 2012 end-page: 92 article-title: The use of adrenaline autoinjectors by children and teenagers publication-title: Clin Exp Allergy – volume: 33 start-page: 1581 year: 2003 end-page: 5 article-title: Presentation of allergen in different food preparations affects the nature of the allergic reaction–a case series publication-title: Clin Exp Allergy – volume: 27 start-page: 539 year: 2016 end-page: 41 article-title: Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports publication-title: Pediatr Allergy Immunol – volume: 313 start-page: 514 year: 1996 end-page: 7 article-title: Cohort study of peanut and tree nut sensitisation by age of 4 years publication-title: BMJ – volume: 135 start-page: 179 year: 2015 end-page: 86 article-title: Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut publication-title: J Allergy Clin Immunol – volume: 61 start-page: 473 year: 2011 end-page: 5 article-title: Diagnosis and assessment of food allergy in children and young people in primary care and community settings: NICE clinical guideline publication-title: Br J Gen Pract – volume: 24 start-page: 596 year: 2013 end-page: 602 article-title: Can we predict severe reactions during peanut challenges in children? publication-title: Pediatr Allergy Immunol – year: 2015 – volume: 131 start-page: 135 year: 2013 end-page: 43 article-title: Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study publication-title: J Allergy Clin Immunol – volume: 45 start-page: 859 year: 2015 end-page: 71 article-title: Dietary management of peanut and tree nut allergy: what exactly should patients avoid? publication-title: Clin Exp Allergy – volume: 45 start-page: 1621 year: 2014 end-page: 36 article-title: Incidence of food anaphylaxis in people with food allergy: a systematic review and meta‐analysis publication-title: Clin Exp Allergy – volume: 69 start-page: 1112 year: 2014 end-page: 4 article-title: The diagnostic accuracy of specific IgE to Ara h 6 in adults is as good as Ara h 2 publication-title: Allergy – volume: 103 start-page: 862 year: 2014 end-page: 7 article-title: Ten‐year review reveals changing trends and severity of allergic reactions to nuts and other foods publication-title: Acta Paediatr – volume: 127 start-page: 668 year: 2011 end-page: 76 article-title: Prevalence of challenge‐proven IgE‐mediated food allergy using population‐based sampling and predetermined challenge criteria in infants publication-title: J Allergy Clin Immunol – volume: 16 start-page: 567 year: 2005 end-page: 73 article-title: The prevalence of food hypersensitivity in an unselected population of children and adults publication-title: Pediatr Allergy Immunol – volume: 74 start-page: 26 year: 1984 end-page: 33 article-title: Comparison of results of skin tests, RAST, and double‐blind, placebo‐controlled food challenges in children with atopic dermatitis publication-title: J Allergy Clin Immunol – volume: 20 start-page: 309 year: 2009 end-page: 19 article-title: The diagnosis of IgE‐mediated food allergy in childhood publication-title: Pediatr Allergy Immunol – volume: 64 start-page: 1218 year: 2009 end-page: 20 article-title: Successful oral tolerance induction in severe peanut allergy publication-title: Allergy – volume: 129 start-page: 1056 year: 2012 end-page: 63 article-title: Increasing the accuracy of peanut allergy diagnosis by using Ara h 2 publication-title: J Allergy Clin Immunol – volume: 123 start-page: 417 year: 2009 end-page: 23 article-title: Household peanut consumption as a risk factor for the development of peanut allergy publication-title: J Allergy Clin Immunol – volume: 71 start-page: 1241 year: 2016 end-page: 55 article-title: Can we identify patients at risk of life‐threatening allergic reactions to food? publication-title: Allergy – volume: 108 start-page: 128 year: 2001 end-page: 32 article-title: A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants publication-title: J Allergy Clin Immunol – volume: 59 start-page: 690 year: 2004 end-page: 7 article-title: Standardization of food challenges in patients with immediate reactions to foods–position paper from the European Academy of Allergology and Clinical Immunology publication-title: Allergy – volume: 14 start-page: 378 year: 2003 end-page: 82 article-title: Assessment of quality of life in children with peanut allergy publication-title: Pediatr Allergy Immunol – volume: 127 start-page: 633 year: 2011 end-page: 9 article-title: Highly accurate prediction of food challenge outcome using routinely available clinical data publication-title: J Allergy Clin Immunol – volume: 67 start-page: 242 year: 2012 end-page: 7 article-title: Basophil allergen threshold sensitivity, CD‐sens, IgE‐sensitization and DBPCFC in peanut‐sensitized children publication-title: Allergy – volume: 27 start-page: 750 year: 2016 end-page: 2 article-title: A retrospect study into the utility of allergen components in walnut allergy publication-title: Pediatr Allergy Immunol – volume: 115 start-page: 108 year: 2015 end-page: 12 article-title: Utility of specific IgE to Ara h 6 in peanut allergy diagnosis publication-title: Ann Allergy Asthma Immunol – volume: 22 start-page: 808 year: 2011 end-page: 12 article-title: Single nut or total nut avoidance in nut allergic children: outcome of nut challenges to guide exclusion diets publication-title: Pediatr Allergy Immunol – volume: 127 start-page: 684 year: 2011 end-page: 5 article-title: Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy publication-title: J Allergy Clin Immunol – volume: 344 start-page: e896 year: 2012 article-title: Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study publication-title: BMJ – volume: 60 start-page: 1440 year: 2005 end-page: 5 article-title: Anaphylactic reactions in children–a questionnaire‐based survey in Germany publication-title: Allergy – volume: 122 start-page: 984 year: 2008 end-page: 91 article-title: Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy publication-title: J Allergy Clin Immunol – volume: 23 start-page: 573 year: 2012 end-page: 81 article-title: Measurement of Ara h 1‐, 2‐, and 3‐specific IgE antibodies is useful in diagnosis of peanut allergy in Japanese children publication-title: Pediatr Allergy Immunol – volume: 64 start-page: 461 year: 2009 end-page: 8 article-title: Impact of peanut allergy on quality of life, stress and anxiety in the family publication-title: Allergy – volume: 135 start-page: 737 year: 2015 end-page: 44 article-title: Administration of a probiotic with peanut oral immunotherapy: a randomized trial publication-title: J Allergy Clin Immunol – volume: 121 start-page: 1331 year: 2008 end-page: 6 article-title: Epidemiologic risks for food allergy publication-title: J Allergy Clin Immunol – volume: 122 start-page: 145 year: 2008 end-page: 51 article-title: The use of serum‐specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy publication-title: J Allergy Clin Immunol – volume: 33 start-page: 1033 year: 2003 end-page: 40 article-title: Anaphylaxis: risk factors for recurrence publication-title: Clin Exp Allergy – volume: 134 start-page: 390 year: 2014 end-page: 8 article-title: Modified oral food challenge used with sensitization biomarkers provides more real‐life clinical thresholds for peanut allergy publication-title: J Allergy Clin Immunol – volume: 58 start-page: 1285 year: 2003 end-page: 92 article-title: Serological characteristics of peanut allergy in children publication-title: Allergy – volume: 27 start-page: 1 issue: Suppl. 23 year: 2016 end-page: 250 article-title: EAACI molecular allergology user's guide publication-title: Pediatr Allergy Immunol – volume: 132 start-page: 630 year: 2013 end-page: 8 article-title: Peanut protein in household dust is related to household peanut consumption and is biologically active publication-title: J Allergy Clin Immunol – year: 2006 – volume: 27 start-page: 452 year: 2016 end-page: 8 article-title: Prevalence and cumulative incidence of food hyper‐sensitivity in the first 10 years of life publication-title: Pediatr Allergy Immunol – volume: 67 start-page: 521 year: 2012 end-page: 7 article-title: Diagnostic value of hazelnut allergy tests including rCor a 1 spiking in double‐blind challenged children publication-title: Allergy – volume: 119 start-page: 1197 year: 2007 end-page: 202 article-title: The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry publication-title: J Allergy Clin Immunol – volume: 21 start-page: 1119 year: 2010 end-page: 26 article-title: Parental satisfaction with oral peanut food challenges; perception of outcomes and impact on management of peanut allergy publication-title: Pediatr Allergy Immunol – volume: 72 start-page: 598 year: 2016 end-page: 603 article-title: Ana o 3‐specific IgE is a good predictor for clinically relevant cashew allergy in children publication-title: Allergy – volume: 117 start-page: 1506 year: 2006 end-page: 8 article-title: Diagnostic accuracy of skin prick testing in children with tree nut allergy publication-title: J Allergy Clin Immunol – volume: 122 start-page: 353 year: 2008 end-page: 61 article-title: Anaphylaxis management plans for the acute and long‐term management of anaphylaxis: a systematic review publication-title: J Allergy Clin Immunol – volume: 71 start-page: 556 year: 2016 end-page: 62 article-title: Cor a 14 is the superior serological marker for hazelnut allergy in children, independent of concomitant peanut allergy publication-title: Allergy – volume: 90 start-page: 640 year: 2003 end-page: 5 article-title: The predictive value of a positive prick skin test to peanut in atopic, peanut‐naive children publication-title: Ann Allergy Asthma Immunol – volume: 70 start-page: 1239 year: 2015 end-page: 45 article-title: Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double‐blind placebo‐controlled study publication-title: Allergy – volume: 122 start-page: 286 year: 2008 end-page: 9 article-title: Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center publication-title: J Allergy Clin Immunol – volume: 121 start-page: 632 year: 2008 end-page: 8 article-title: Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center publication-title: J Allergy Clin Immunol – volume: 121 start-page: 731 year: 2008 end-page: 6 article-title: Early clinical predictors of remission of peanut allergy in children publication-title: J Allergy Clin Immunol – ident: e_1_2_18_100_1 doi: 10.1111/all.12820 – ident: e_1_2_18_155_1 doi: 10.1016/j.jaci.2014.11.034 – ident: e_1_2_18_73_1 doi: 10.1111/j.1399-3038.2007.00517.x – ident: e_1_2_18_91_1 doi: 10.1111/all.12671 – ident: e_1_2_18_67_1 doi: 10.1016/0091-6749(84)90083-6 – ident: e_1_2_18_66_1 doi: 10.1111/j.1398-9995.2011.02754.x – ident: e_1_2_18_112_1 doi: 10.1067/mai.2003.1517 – ident: e_1_2_18_60_1 doi: 10.1046/j.1365-2222.2003.01795.x – ident: e_1_2_18_31_1 doi: 10.1016/j.jaci.2013.03.043 – ident: e_1_2_18_102_1 doi: 10.1111/j.1365-2222.2009.03312.x – ident: e_1_2_18_93_1 doi: 10.1111/all.12424 – ident: e_1_2_18_110_1 doi: 10.1046/j.1365-2745.2003.01624.x – ident: e_1_2_18_144_1 doi: 10.1016/j.jaci.2015.01.002 – ident: e_1_2_18_9_1 doi: 10.1136/bmj.313.7056.514 – ident: e_1_2_18_49_1 doi: 10.1016/j.jaci.2014.09.001 – ident: e_1_2_18_135_1 doi: 10.1111/all.12628 – ident: e_1_2_18_124_1 doi: 10.1111/cea.12466 – ident: e_1_2_18_141_1 doi: 10.1111/j.1398-9995.2010.02343.x – ident: e_1_2_18_59_1 doi: 10.1067/mai.2003.1486 – ident: e_1_2_18_64_1 doi: 10.1067/mai.2002.124775 – ident: e_1_2_18_150_1 doi: 10.1111/j.1365-2222.2011.03699.x – ident: e_1_2_18_153_1 doi: 10.1186/2045-7022-4-30 – ident: e_1_2_18_43_1 doi: 10.1046/j.1365-2222.2003.01671.x – ident: e_1_2_18_129_1 doi: 10.1111/cea.12788 – ident: e_1_2_18_2_1 doi: 10.1034/j.1399-3038.2003.00072.x – ident: e_1_2_18_108_1 doi: 10.1111/j.1399-3038.2011.01191.x – ident: e_1_2_18_34_1 doi: 10.1056/NEJMoa013536 – ident: e_1_2_18_104_1 doi: 10.1016/j.jaci.2015.03.037 – ident: e_1_2_18_122_1 doi: 10.1016/j.jaci.2006.04.024 – ident: e_1_2_18_3_1 doi: 10.1111/j.1398-9995.2008.01843.x – ident: e_1_2_18_72_1 doi: 10.1111/j.1399-3038.2007.00519.x – ident: e_1_2_18_113_1 doi: 10.1111/j.1398-9995.2009.01982.x – ident: e_1_2_18_19_1 doi: 10.1034/j.1398-9995.1999.00768.x – ident: e_1_2_18_152_1 doi: 10.1016/j.jaci.2009.05.022 – ident: e_1_2_18_7_1 doi: 10.1111/j.1398-9995.2009.02176.x – ident: e_1_2_18_24_1 doi: 10.1016/S0091-6749(99)70224-1 – ident: e_1_2_18_27_1 doi: 10.1016/j.jaci.2014.10.021 – ident: e_1_2_18_36_1 doi: 10.1016/j.jaci.2013.02.034 – ident: e_1_2_18_14_1 doi: 10.1016/j.jaci.2007.05.026 – ident: e_1_2_18_96_1 doi: 10.1016/j.jaip.2012.08.007 – ident: e_1_2_18_44_1 doi: 10.1111/all.12924 – ident: e_1_2_18_106_1 doi: 10.1111/cea.12693 – ident: e_1_2_18_146_1 doi: 10.1016/j.jaci.2005.09.002 – ident: e_1_2_18_105_1 doi: 10.1111/cea.12267 – ident: e_1_2_18_51_1 doi: 10.1111/j.1365-2222.2011.03912.x – ident: e_1_2_18_29_1 doi: 10.1034/j.1398-9995.2001.056003252.x – ident: e_1_2_18_77_1 doi: 10.1111/j.1399-3038.2009.00887.x – ident: e_1_2_18_40_1 doi: 10.1542/peds.102.1.e6 – ident: e_1_2_18_101_1 doi: 10.1016/j.jaci.2012.05.019 – ident: e_1_2_18_89_1 doi: 10.1111/all.12530 – ident: e_1_2_18_46_1 doi: 10.1016/j.jaci.2005.11.035 – ident: e_1_2_18_114_1 doi: 10.1111/j.1399-3038.2009.00975.x – ident: e_1_2_18_145_1 doi: 10.1016/j.jaip.2013.05.008 – ident: e_1_2_18_94_1 doi: 10.1007/s00431-016-2733-7 – ident: e_1_2_18_52_1 doi: 10.1016/j.jaci.2010.02.009 – ident: e_1_2_18_65_1 doi: 10.1542/peds.101.3.e8 – ident: e_1_2_18_143_1 doi: 10.1067/mai.2001.112129 – ident: e_1_2_18_156_1 doi: 10.1016/j.jaci.2010.04.030 – ident: e_1_2_18_81_1 doi: 10.1016/j.jaci.2010.01.057 – ident: e_1_2_18_154_1 doi: 10.1016/j.jaci.2010.12.1083 – ident: e_1_2_18_41_1 doi: 10.1016/j.jaci.2008.04.014 – ident: e_1_2_18_85_1 doi: 10.1016/j.jaip.2012.11.002 – ident: e_1_2_18_33_1 doi: 10.1111/cea.12466 – ident: e_1_2_18_90_1 doi: 10.1111/j.1365-2222.2007.02764.x – ident: e_1_2_18_87_1 doi: 10.1067/mai.2000.103052 – ident: e_1_2_18_88_1 doi: 10.1111/pai.12563 – ident: e_1_2_18_42_1 doi: 10.1111/j.1398-9995.2005.00909.x – ident: e_1_2_18_130_1 doi: 10.3399/bjgp17X689917 – ident: e_1_2_18_5_1 doi: 10.1111/pai.12554 – ident: e_1_2_18_61_1 doi: 10.1111/apa.12687 – ident: e_1_2_18_55_1 doi: 10.1136/adc.85.4.348b – ident: e_1_2_18_115_1 doi: 10.1111/j.1399-3038.2012.01310.x – ident: e_1_2_18_139_1 doi: 10.1016/j.jaci.2008.05.028 – ident: e_1_2_18_8_1 doi: 10.1136/bmj.312.7038.1074 – ident: e_1_2_18_140_1 – ident: e_1_2_18_47_1 doi: 10.1111/j.1399-3038.2010.01043.x – ident: e_1_2_18_107_1 doi: 10.1111/pai.12610 – ident: e_1_2_18_54_1 doi: 10.1016/j.jaci.2007.01.021 – ident: e_1_2_18_20_1 doi: 10.1111/j.1398-9995.2007.01570.x – ident: e_1_2_18_56_1 doi: 10.1097/WOX.0b013e318211496c – ident: e_1_2_18_68_1 doi: 10.1046/j.1365-2222.2000.00928.x – ident: e_1_2_18_97_1 doi: 10.1016/j.jaci.2013.02.024 – ident: e_1_2_18_120_1 doi: 10.1016/S0140-6736(08)60659-5 – ident: e_1_2_18_35_1 doi: 10.1016/j.jaci.2008.12.014 – ident: e_1_2_18_38_1 doi: 10.1111/cea.12406 – ident: e_1_2_18_16_1 doi: 10.1056/NEJMoa1514210 – ident: e_1_2_18_23_1 doi: 10.1016/j.jaci.2010.03.029 – ident: e_1_2_18_39_1 doi: 10.1016/j.jaci.2012.09.015 – ident: e_1_2_18_22_1 doi: 10.1111/pai.12564 – ident: e_1_2_18_30_1 doi: 10.1016/j.jaci.2008.04.032 – ident: e_1_2_18_57_1 doi: 10.3399/bjgp11X583498 – ident: e_1_2_18_21_1 doi: 10.1016/S1081-1206(10)61994-1 – ident: e_1_2_18_95_1 doi: 10.1111/cea.12136 – ident: e_1_2_18_149_1 doi: 10.1111/all.12956 – ident: e_1_2_18_80_1 doi: 10.1016/j.jaci.2004.07.063 – ident: e_1_2_18_58_1 doi: 10.1046/j.1365-2222.2000.00960.x – ident: e_1_2_18_92_1 doi: 10.1016/j.anai.2015.05.015 – ident: e_1_2_18_131_1 doi: 10.1111/all.12437 – ident: e_1_2_18_15_1 doi: 10.1016/j.jaci.2011.01.039 – ident: e_1_2_18_132_1 doi: 10.1111/pai.12048 – ident: e_1_2_18_109_1 doi: 10.1111/j.1399-3038.2011.01264.x – volume-title: Food Allergen Labelling Technical Guidance year: 2015 ident: e_1_2_18_116_1 – ident: e_1_2_18_48_1 doi: 10.1111/pai.12107 – ident: e_1_2_18_69_1 doi: 10.1016/S1081-1206(10)61869-8 – ident: e_1_2_18_18_1 doi: 10.1016/j.jaci.2009.10.008 – volume: 10 start-page: 173 year: 2000 ident: e_1_2_18_126_1 article-title: Allergy to Anacardiaceae: description of cashew and pistachio nut allergens publication-title: J Investig Allergol Clin Immunol – ident: e_1_2_18_28_1 doi: 10.1067/mai.2001.115755 – ident: e_1_2_18_25_1 doi: 10.1111/j.1399-3038.2005.00251.x – ident: e_1_2_18_75_1 doi: 10.1016/j.jaci.2013.05.038 – ident: e_1_2_18_121_1 doi: 10.1016/j.jaci.2007.07.015 – ident: e_1_2_18_133_1 doi: 10.1111/j.1399-3038.2006.00392.x – ident: e_1_2_18_45_1 doi: 10.1111/j.1399-3038.2010.01063.x – ident: e_1_2_18_99_1 doi: 10.1016/j.jaip.2015.12.012 – ident: e_1_2_18_63_1 doi: 10.1016/j.jaci.2010.12.012 – ident: e_1_2_18_17_1 doi: 10.1111/pai.12337 – ident: e_1_2_18_103_1 doi: 10.1111/all.13050 – volume: 43 start-page: 1462 year: 2013 ident: e_1_2_18_147_1 article-title: Behaviours towards siblings of children with nut allergy; how might these influence management? publication-title: Clin Exp Allergy – ident: e_1_2_18_62_1 doi: 10.1016/j.jaci.2007.12.003 – ident: e_1_2_18_82_1 doi: 10.1016/j.jaci.2010.12.004 – ident: e_1_2_18_10_1 doi: 10.1016/j.jaci.2005.05.047 – ident: e_1_2_18_84_1 doi: 10.1016/j.jaci.2012.01.056 – ident: e_1_2_18_119_1 – ident: e_1_2_18_53_1 doi: 10.1136/bmj.e896 – ident: e_1_2_18_12_1 doi: 10.1016/j.jaci.2006.12.670 – ident: e_1_2_18_79_1 doi: 10.1046/j.1398-9995.2003.00300.x – ident: e_1_2_18_71_1 doi: 10.1016/j.jaci.2006.03.029 – ident: e_1_2_18_118_1 doi: 10.1067/mai.2001.119157 – ident: e_1_2_18_26_1 doi: 10.1111/cea.12477 – ident: e_1_2_18_111_1 doi: 10.1111/j.1398-9995.2004.00466.x – ident: e_1_2_18_70_1 doi: 10.1111/j.1399-3038.2005.00305.x – ident: e_1_2_18_86_1 doi: 10.1111/all.12075 – ident: e_1_2_18_125_1 doi: 10.1046/j.1398-9995.2003.00342.x – ident: e_1_2_18_4_1 doi: 10.1016/j.jaci.2008.05.015 – ident: e_1_2_18_83_1 doi: 10.1111/j.1399-3038.2012.01332.x – ident: e_1_2_18_151_1 doi: 10.1016/j.jaci.2014.03.035 – ident: e_1_2_18_136_1 doi: 10.1002/0470861193.ch10 – ident: e_1_2_18_32_1 doi: 10.1016/j.jaci.2011.01.031 – ident: e_1_2_18_127_1 doi: 10.1111/j.1365-2222.2008.02998.x – ident: e_1_2_18_148_1 doi: 10.1186/1710-1492-4-4-144 – ident: e_1_2_18_13_1 doi: 10.1016/j.jaci.2008.08.039 – ident: e_1_2_18_123_1 doi: 10.1067/mpd.2000.109376 – ident: e_1_2_18_6_1 doi: 10.1016/j.jaci.2009.03.050 – volume-title: Food Allergy Care Pathway year: 2006 ident: e_1_2_18_137_1 – ident: e_1_2_18_142_1 doi: 10.1016/j.jaci.2007.11.024 – ident: e_1_2_18_78_1 doi: 10.1016/S0091-6749(97)70133-7 – ident: e_1_2_18_134_1 doi: 10.1111/pai.12261 – ident: e_1_2_18_128_1 doi: 10.1016/S1081-1206(10)61187-8 – ident: e_1_2_18_98_1 doi: 10.1111/j.1399-3038.2010.01088.x – ident: e_1_2_18_37_1 doi: 10.1056/NEJMoa1414850 – ident: e_1_2_18_50_1 doi: 10.1111/j.1651-2227.2005.tb01966.x – ident: e_1_2_18_76_1 doi: 10.1111/j.1398-9995.2011.02766.x – ident: e_1_2_18_11_1 doi: 10.1016/j.jaci.2014.12.1053 – ident: e_1_2_18_74_1 doi: 10.1111/j.1365-2222.2011.03717.x – volume-title: Allergen Labelling year: 2013 ident: e_1_2_18_117_1 – ident: e_1_2_18_138_1 doi: 10.1111/j.1399-3038.2005.00310.x – reference: 28763130 - Clin Exp Allergy. 2017 Sep;47(9):1223-1224. doi: 10.1111/cea.12991. |
| SSID | ssj0003598 |
| Score | 2.5302696 |
| Snippet | Summary
Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological... Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data... Summary Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 719 |
| SubjectTerms | adrenaline aetiology Allergens - immunology Allergies almond anaphylaxis Anti-Allergic Agents - administration & dosage Anti-Allergic Agents - therapeutic use Antibody Specificity - immunology Arachis - adverse effects Brazil cashew Children Cost of Illness Diagnosis Diet Therapy - methods Disease Management Eczema Emergency Medical Services epicutaneous immunotherapy epinephrine Food Food allergies Hay fever hazelnut Humans Immunoglobulin E Immunoglobulin E - immunology Immunotherapy - methods Infants macadamia macadamia food allergy management Nut Hypersensitivity - diagnosis Nut Hypersensitivity - epidemiology Nut Hypersensitivity - prevention & control Nut Hypersensitivity - therapy Nuts Nuts - adverse effects oral oral allergy syndrome Patient Education as Topic peanut Peanut Hypersensitivity - diagnosis Peanut Hypersensitivity - epidemiology Peanut Hypersensitivity - prevention & control Peanut Hypersensitivity - therapy Peanuts pecan Pharynx pistachio Pollen pollen food syndrome Prevalence Quality of Life Risk Factors Skin tests Skin Tests - methods sublingual Symptom Assessment tree nut walnut |
| Title | BSACI guideline for the diagnosis and management of peanut and tree nut allergy |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcea.12957 https://www.ncbi.nlm.nih.gov/pubmed/28836701 https://www.proquest.com/docview/1904793998 https://www.proquest.com/docview/1932169278 |
| Volume | 47 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB4WQfHiY32trhLFg5cubdOmLZ7WVVFhFdQFD0JJ0lRE7Yq7PeivN5M-dH2AeGubKUmTTOfLTPINwK6kEU8DoawklNLyJBWWsIVrpTYVTESMe4aOoX_OTgbe2Y1_04D96ixMwQ9RO9xQM8z_GhWci9EnJZeKd7Sx8vEkuUMZ8uYfXn5QRyEzXcGz51lBGHklqxDu4qnfnLRF3wDmJF41Bud4Hm6rphb7TB46-Vh05NsXFsd_fssCzJVAlHSLmbMIDZU1YbpITfnahJl-GXRfgouDq27vlNzlyIilnxCNc4nGjSQptundjwjPEvJUb6Qhw5Sghz8fmwKMexNzg8cO716XYXB8dN07sco8DJb0nCiwhBvaaaJC2-eo8twNEg0UbOoqyhWn1GciTZwopFL5IeIXX0UO9e2UYpDQSegKTGXDTK0BkXo9JwPmKRYlnoY-Qq-gZGoLoU2p0sIt2KtGJJYlSTnmyniMq8WK7qrYdFULdmrR54KZ4yehdjWscamco1hjIPQn6oVmC7brYq1WGCvhmRrmKENdh0UuNmm1mA51LZigmQW2oxtrBvX36uPeUddcrP9ddANmXYQOxtPThqnxS642NfAZiy0zw98BDSX6jw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKlouUJ5dSotBHLhklcTOS-pluwUtjwWpgMQFRbbjoArIVrA5wK9nxnkUaJEQtySeyI7tyXwztr8B2NQ8kXmkjJPFWjtCc-UoV_lO7nIVqiSUwtIxDA_DwanYOwvOJuB7cxam4odoA26kGfZ_TQpOAelHWq6N7KK1CqJ38F4g0CDX6-evv-RRxE1XMe0JJ4oTUfMK0T6e9tWn1ugfiPkUsVqTszML501jq50ml91yrLr6_hmP41u_5hPM1FiU9arJMwcTppiHqSo75d08fBjW6-4LcPTjuNffZRclkWLhE4ZQlyF0ZFm1U-_3LZNFxq7bvTRslDMK8pdjW0BL38ze0MnDi7tFON3ZPukPnDoVg6OFl0SO8mM3z0zsBpK0XvpRhljB5b7h0kjOg1DlmZfEXJsgJggTmMTjgZtzWif0Mr4Ek8WoMJ-BaXTpdBQKEyaZQPSj0InSuasUWlODwh3YaoYk1TVPOaXLuEobfwW7KrVd1YGNVvRPRc7xP6HVZlzTWj9vU4RBFFJEX7MD620xahYtl8jCjEqS4b4XJj41abmaD20tlKM5jFwPG2tH9eXq0_52z16svF50DT4OToYH6cHu4f4XmPYJSdjAzypMjm9K8xVx0Fh9s9P9AcmW_q4 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKhCXttDXthRM1UMvWSWx4yTqabtlxZuqLRIHpMivIATNorI50F_fGedB6UNC3JJ4Iju2J_N5PP4G4J3huSpT7QKbGRMIw3WgQx0HZci11LlUwtMx7B_IrSOxc5wcz8GH7ixMww_RO9xIM_z_mhT80pa_KblxaojGKkkfwEMhEUkQIvpywx1F1HQN0Z4I0iwXLa0QhfH0r942Rn8hzNuA1VucyWM46draBJqcD-uZHpqff9A43vNjnsCjFomyUTN1lmHOVSuw0OSmvF6Bxf121_0pHH78Ohpvs9OaKLHwCUOgyxA4MtvE6Z1dMVVZ9r2PpGHTkpGLv575Atr4Zv6Gzh2eXj-Do8nmt_FW0CZiCIyI8jTQcRaW1mVhokjnVZxaRAohjx1XTnGeSF3aKM-4cUlGACZxecSTsOS0SxhZ_hzmq2nlXgIzuKAzqRRO5lYg9tG4hDJlqDXaUofCA3jfjUhhWpZySpZxUXSrFeyqwnfVAN72opcNNce_hFa7YS1a7bwqEASRQxFXmgPY6ItRr2izRFVuWpMMjyOZx9SkF8106GuhDM0yDSNsrB_U_1dfjDdH_uLV3UXXYfHzp0mxt32w-xqWYoIR3uuzCvOzH7V7gyBoptf8ZP8Fx8b9XQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BSACI+guideline+for+the+diagnosis+and+management+of+peanut+and+tree+nut+allergy&rft.jtitle=Clinical+and+experimental+allergy&rft.au=Stiefel%2C+G&rft.au=Anagnostou%2C+K&rft.au=Boyle%2C+R+J&rft.au=Brathwaite%2C+N&rft.date=2017-06-01&rft.issn=1365-2222&rft.eissn=1365-2222&rft.volume=47&rft.issue=6&rft.spage=719&rft_id=info:doi/10.1111%2Fcea.12957&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-7894&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-7894&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-7894&client=summon |